Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction
Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood–brain barrier under hypoxia/reoxygenation
Cilostazol
[Cilostazol].
CILOSTAZOL